429 related articles for article (PubMed ID: 36428741)
1. Preclinical Models of Neuroendocrine Neoplasia.
Sedlack AJH; Saleh-Anaraki K; Kumar S; Ear PH; Lines KE; Roper N; Pacak K; Bergsland E; Quelle DE; Howe JR; Pommier Y; Del Rivero J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428741
[TBL] [Abstract][Full Text] [Related]
2. Mouse models in endocrine tumors.
Gahete MD; Jimenez-Vacas JM; Alors-Perez E; Herrero-Aguayo V; Fuentes-Fayos AC; Pedraza-Arevalo S; Castaño JP; Luque RM
J Endocrinol; 2018 Nov; ():. PubMed ID: 30475226
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
Kawasaki K; Fujii M; Sato T
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells and CDX models as a tool for preclinical drug development.
Lallo A; Schenk MW; Frese KK; Blackhall F; Dive C
Transl Lung Cancer Res; 2017 Aug; 6(4):397-408. PubMed ID: 28904884
[TBL] [Abstract][Full Text] [Related]
5. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenografts as preclinical neuroblastoma models.
Braekeveldt N; Bexell D
Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
[TBL] [Abstract][Full Text] [Related]
7. Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions.
Detjen K; Hammerich L; Özdirik B; Demir M; Wiedenmann B; Tacke F; Jann H; Roderburg C
Neuroendocrinology; 2021; 111(3):217-236. PubMed ID: 32615560
[TBL] [Abstract][Full Text] [Related]
8. Harnessing preclinical models for the interrogation of ovarian cancer.
Qin T; Fan J; Lu F; Zhang L; Liu C; Xiong Q; Zhao Y; Chen G; Sun C
J Exp Clin Cancer Res; 2022 Sep; 41(1):277. PubMed ID: 36114548
[TBL] [Abstract][Full Text] [Related]
9. From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.
Yu C; Hu K; Nguyen D; Wang ZA
Am J Cancer Res; 2019; 9(10):2079-2102. PubMed ID: 31720076
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.
Arnal-Estapé A; Foggetti G; Starrett JH; Nguyen DX; Politi K
Cold Spring Harb Perspect Med; 2021 Dec; 11(12):. PubMed ID: 34518338
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered mouse models for studying radiation biology.
Castle KD; Chen M; Wisdom AJ; Kirsch DG
Transl Cancer Res; 2017 Jul; 6(Suppl 5):S900-S913. PubMed ID: 30733931
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived cell line, xenograft and organoid models in lung cancer therapy.
Huo KG; D'Arcangelo E; Tsao MS
Transl Lung Cancer Res; 2020 Oct; 9(5):2214-2232. PubMed ID: 33209645
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
Lawrence MG; Obinata D; Sandhu S; Selth LA; Wong SQ; Porter LH; Lister N; Pook D; Pezaro CJ; Goode DL; Rebello RJ; Clark AK; Papargiris M; Van Gramberg J; Hanson AR; Banks P; Wang H; Niranjan B; Keerthikumar S; Hedwards S; Huglo A; Yang R; Henzler C; Li Y; Lopez-Campos F; Castro E; Toivanen R; Azad A; Bolton D; Goad J; Grummet J; Harewood L; Kourambas J; Lawrentschuk N; Moon D; Murphy DG; Sengupta S; Snow R; Thorne H; Mitchell C; Pedersen J; Clouston D; Norden S; Ryan A; Dehm SM; Tilley WD; Pearson RB; Hannan RD; Frydenberg M; Furic L; Taylor RA; Risbridger GP
Eur Urol; 2018 Nov; 74(5):562-572. PubMed ID: 30049486
[TBL] [Abstract][Full Text] [Related]
14. Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms.
von Arx C; Capozzi M; López-Jiménez E; Ottaiano A; Tatangelo F; Di Mauro A; Nasti G; Tornesello ML; Tafuto S
J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31443481
[TBL] [Abstract][Full Text] [Related]
15. Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer.
Wadosky KM; Wang Y; Zhang X; Goodrich DW
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31259888
[TBL] [Abstract][Full Text] [Related]
16. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Fang JM; Li J; Shi J
World J Gastroenterol; 2022 Mar; 28(10):1009-1023. PubMed ID: 35431496
[TBL] [Abstract][Full Text] [Related]
17. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.
Viol F; Sipos B; Fahl M; Clauditz TS; Amin T; Kriegs M; Nieser M; Izbicki JR; Huber S; Lohse AW; Schrader J
Cell Oncol (Dordr); 2022 Dec; 45(6):1401-1419. PubMed ID: 36269546
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
[TBL] [Abstract][Full Text] [Related]
19. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
